Tahir Misbah 4
4 · IGM Biosciences, Inc. · Filed Nov 29, 2023
Insider Transaction Report
Form 4
Tahir Misbah
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2023-11-15$11.71/sh+234$2,740→ 50,945 total - Sale
Common Stock
2023-11-27$5.06/sh−1,337$6,764→ 49,608 total
Footnotes (3)
- [F1]The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]This transaction was executed in multiple trades at prices ranging from $4.96 to $5.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.